4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-19-001302
Options or other derivatives
- Chief Financial Officer acquired 1,538,640 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X03/a4.xml…